Quick Takeaways
- Meridian Venture Partners II GP, L.P. filed SCHEDULE 13D/A for ANI Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ANIP).
- Disclosed ownership: 5.4%.
- Date of event: 11 Mar 2025.
Quoteable Key Fact
"Meridian Venture Partners II GP, L.P. disclosed 5.4% ownership in ANI Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ANIP) on 11 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Meridian Venture Partners II GP, L.P. ("GP") | 5.4% | 1,164,381 | 0 | 1,164,381 | /s/ Robert E. Brown, Jr. | Robert E. Brown, Jr. | 0001580170 |
| Meridian Venture Partners II, L.P. | 5.4% | 1,164,381 | 0 | 1,164,381 | /s/ Robert E. Brown, Jr. | Robert E. Brown, Jr. | 0001109507 |
| Meridian Venture Partners II, Co. | 5.4% | 1,164,381 | 0 | 1,164,381 | /s/ Robert E. Brown, Jr. | Robert E. Brown, Jr. | 0001580169 |
| Robert E. Brown, Jr. | 5.4% | 1,184,570 | 20,189 | 1,164,381 | /s/ Robert E. Brown, Jr. | Robert E. Brown, Jr. | 0001579672 |